Morgan Stanley’s Ardent Health ARDT Stock Holding History

Morgan Stanley’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11M	Buy	315,960 +23,929	+8%	+$227K	﹤0.01%	4566
2026 Q1	$2.5M	Sell	292,031 -435,338	-60%	-$3.91M	﹤0.01%	4605
2025 Q4	$6.42M	Buy	727,369 +145,927	+25%	+$1.69M	﹤0.01%	3990
2025 Q3	$7.7M	Buy	581,442 +154,564	+36%	+$1.93M	﹤0.01%	3783
2025 Q2	$5.83M	Buy	426,878 +74,608	+21%	+$1M	﹤0.01%	3933
2025 Q1	$4.84M	Buy	352,270 +84,147	+31%	+$1.23M	﹤0.01%	3955
2024 Q4	$4.58M	Buy	268,123 +12,146	+5%	+$211K	﹤0.01%	4074
2024 Q3	$4.7M	Buy	+255,977	New	+$4.52M	﹤0.01%	4005

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return

Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley's ARDT Position: Q2 2026 in Review

Morgan Stanley increased its Ardent Health (ARDT) stake by 8.2% in Q2 2026, buying an estimated $227K and bringing the position to 315,960 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #4566.

Morgan Stanley first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.7M in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

Morgan Stanley held 315,960 shares of Ardent Health worth $3.11M as of Q2 2026.
Morgan Stanley bought 23,929 Ardent Health shares in Q2 2026, an estimated $227K.
Ardent Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4566 holding.
Morgan Stanley first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
Morgan Stanley's Ardent Health position peaked at $7.7M in Q3 2025.
139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.